Burns J A, Friedman A D, Lutch M J, Hillman R E, Zeitels S M
Department of Surgery, Center for Laryngeal Surgery and Voice Rehabilitation, Massachusetts General Hospital, Harvard Medical School, One Bowdoin Square, 11th Floor, Boston, MA 02114, USA.
J Laryngol Otol. 2010 Apr;124(4):407-11. doi: 10.1017/S0022215109991824. Epub 2009 Nov 27.
Recently, the 532 nm pulsed potassium-titanyl-phosphate laser has emerged as an effective angiolytic laser for treating mucosal lesions of the larynx in the operating theatre and clinic. We sought to assess the current impact of potassium-titanyl-phosphate laser on our laryngeal surgery practice.
Retrospective review of 710 patients undergoing endoscopic laryngeal surgery over a one-year period.
Medical records of the endoscopic laryngeal procedures were reviewed; 386/710 had been performed in the clinic and 324/710 in the operating theatre under general anaesthesia. Indications for the procedures were classified by pathology.
Pulsed potassium-titanyl-phosphate laser was used in 209/386 clinic procedures. The indications for these procedures were: dysplasia (114/209 procedures), papillomatosis (89/209), varices or ectasia (three of 209), and 'other' (three of 209). Pulsed potassium-titanyl-phosphate laser was used in 178/324 operating theatre endoscopic laryngeal procedures. The indications for these procedures were: cancer (54/178 procedures), dysplasia (52/178), papillomatosis (38/178), varices or ectasia (13/178), polyps (six of 178), nodules (six of 178), stenosis (five of 178), granulation (three of 178), and amyloid (one of 178).
Due to its versatility, the 532 nm pulsed potassium-titanyl-phosphate laser is our most commonly utilised instrument for performing endoscopic laryngeal surgery.
最近，532 纳米脉冲磷酸钛钾激光已成为一种有效的血管消融激光，用于在手术室和诊所治疗喉部黏膜病变。我们试图评估磷酸钛钾激光对我们喉部手术实践的当前影响。
对 710 例在一年期间接受内镜喉部手术的患者进行回顾性研究。
回顾内镜喉部手术的病历；710 例中有 386 例在诊所进行，324 例在手术室全身麻醉下进行。手术适应症按病理分类。
209/386 例诊所手术使用了脉冲磷酸钛钾激光。这些手术的适应症为：发育异常（209 例中的 114 例）、乳头状瘤病（209 例中的 89 例）、静脉曲张或扩张（209 例中的 3 例）以及“其他”（209 例中的 3 例）。178/324 例手术室内镜喉部手术使用了脉冲磷酸钛钾激光。这些手术的适应症为：癌症（178 例中的 54 例）、发育异常（178 例中的 52 例）、乳头状瘤病（178 例中的 38 例）、静脉曲张或扩张（178 例中的 13 例）、息肉（178 例中的 6 例）、结节（178 例中的 6 例）、狭窄（178 例中的 5 例）、肉芽组织（178 例中的 3 例）以及淀粉样变性（178 例中的 1 例）。
由于其多功能性，532 纳米脉冲磷酸钛钾激光是我们进行内镜喉部手术最常用的器械。
